Navigation Links
Anthera Pharmaceuticals Reports 2013 Second Quarter Financial Results
Date:7/30/2013

HAYWARD, Calif., July 30, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and business highlights for the quarter ended June 30, 2013.

Second Quarter 2013 Financial Results: Loss from operations decreased in the second quarter of 2013 to $7.0 million from $16.7 million in the second quarter of 2012, and to $13.9 million for the six months ended June 30, 2013 compared to $36.7 million for the comparable period in 2012.  The decreases in loss from operations primarily resulted from a decrease in research and development expenses due to the Company's shift in focus to the development of blisibimod for systemic lupus erythematosus, or lupus, and IgA nephropathy, an orphan disease in the United States.  

Net loss for the quarter ended June 30, 2013 was $8.3 million, or $0.43 loss per basic and diluted share, compared with a net loss of $17.6 million, or $3.43 loss per basic and diluted share for the quarter ended June 30, 2012. Net loss in the current quarter included a non-cash charge of $0.5 million in unamortized note discount and debt issuance cost as a result of the Company's successful restructuring of its debt obligations with Hercules Technology Growth Capital. The Company reported a net loss of $15.9 million or $0.92 per basic and diluted share for the six months ended June 30, 2013, compared with a net loss of $38.5 million or $7.51 per basic and diluted share for the comparable period in 2012. The decrease in net losses per basic and diluted share in 2013 as compared to 2012 both quarterly and year-to-date were primarily due to the result of lower loss from operations, and higher common shares outstanding attributable to the closing of an underwritten public offering of 8,712,119 shares of the Company's common stock in January 2013 from which the Co
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anthera Announces Initiation of BRIGHT-SC Phase 2 Clinical Study in IgA Nephropathy with Blisibimod
2. Anthera Pharmaceuticals Announces Receipt of Nasdaq Notice
3. Anthera Pharmaceuticals Announces Personnel Changes
4. Anthera Pharmaceuticals to Present at Annual Jefferies Healthcare Conference
5. Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results
6. Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC Blisibimod Study
7. Anthera Refinances Existing Debt with New $20 Million Credit Facility and Secures $18.5 Million Committed Equity Financing Facility
8. Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
9. Anthera Announces Data from the Phase 2b PEARL-SC Study Will Be Presented at the 10th International Congress on Systemic Lupus Erythematosus
10. Anthera Pharmaceuticals to Present at the 2013 Leerink Global Healthcare Conference
11. Anthera Pharmaceuticals Announces Departure of Georgina Kilfoil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... Research and Markets ( ... "North American Active Wound Care Market by ... & Ulcer), by End-User (In-Patient, & Out-Paient) - ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The North ... grow at a CAGR of 3.1% from 2014 ...
(Date:5/21/2015)... ATLANTA , May 21, 2015  CryoLife, Inc. ... tissue processing company focused on cardiac and vascular surgery, ... a quarterly cash dividend for the second quarter 2015 ... quarterly cash dividend of $0.03 per share will be ... of record as of June 12, 2015.  The ex-dividend ...
(Date:5/21/2015)... May 21, 2015 The Pharmaceutical Care ... the Medicare Part D offsets included in the ... "If the 21st Century Cures initiative can ... premier health program – Medicare – then its ... down the road. "Leveraging payments to ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... 18 Breathe Technologies, Inc., a manufacturer of ... chronic obstructive pulmonary disease and sleep apnea, announced today ... C financing. The financing was led by DAG Ventures ... (KPCB), Delphi Ventures, Synergy Partners International and Johnson & ...
... SUNNYVALE, Calif. , May 18 Accuray Incorporated (Nasdaq: ARAY ... Vittorio Puppo , M.D.,  has joined Accuray as General Manager of the EIMEA ... 2010 . , , , ... Puppo worked for Covidien, a healthcare device and supply company, where he served ...
Cached Medicine Technology:Breathe Technologies Secures $23 Million in Series C Financing 2Accuray Hires General Manager for the EIMEA Region 2Accuray Hires General Manager for the EIMEA Region 3Accuray Hires General Manager for the EIMEA Region 4
(Date:5/26/2015)... 26, 2015 The Brain Aneurysm Foundation ... Pops and their renowned Conductor Keith Lockhart will once ... evening, June 10, 2015—the 4th Annual Brain Aneurysm ... Pops Night is set to feature an exclusive Brain ... Keith Lockhart who tragically lost his sister-in-law to a ...
(Date:5/26/2015)... Carl W. Berk, M.D. and his fellow ... N.C. have launched a Balloon Sinuplasty website to inform ... and the benefits of Balloon Sinuplasty. , The website ... if someone is a good candidate for Balloon Sinuplasty. ... that can contribute to chronic nasal congestion. If the ...
(Date:5/25/2015)... 2015 The National Association of ... as a 2015-2016 inductee into its VIP Professional Woman ... prestigious distinction for leadership in real estate. NAPW is ... boasting more than 700,000 members and over 200 operating ... into this exceptional group of professional women," said NAPW ...
(Date:5/25/2015)... New York (PRWEB) May 25, 2015 ... of patented products, launches The Preventer, a home patent ... the dangers of fire. , "House fires cost the ... Scott J. Cooper, CEO and Creative Director of ... fire deaths result from homes that have no alarmed ...
(Date:5/25/2015)... May 25, 2015 According to a ... market growth in hip external fixation market is driven ... U.S. population and advancements in infection prevention technologies. As ... fractures are currently accounting for the largest total number ... with falls and accidents. As a result, the average ...
Breaking Medicine News(10 mins):Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2Health News:National Association of Professional Women Inducts Anne King, Operating Principal at Keller Williams, Into its VIP Professional Woman of the Year Circle 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 2Health News:Home Maintenance Causes House Fires? World Patent Marketing Introduces the Best Home Patent to Prevent Fire Accidents 3Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 2Health News:DePuy Synthes and Stryker Lead Orthopedic External Fixation Trauma Device Market Due to Increased Hip Fractures in the U.S. 3
... , CARDIFF, Calif., Nov. 19 ... ( www.jedimindinc.com ), a thought-controlled and mind-controlled gaming ... regarding the developments of the Company, new products coming out ... on CNBC and CNN Headline News. , The Company ...
... can wear off at higher levels in men, study finds , ... that long-term moderate drinking decreased the risk of heart disease by ... women. , The type of alcohol -- beer, wine or spirits ... online issue of Heart . The Spanish analysis used 10-year ...
... A pediatric immunologist at The Children,s Hospital of ... the American Philosophical Society, an organization founded in ... Ph.D., received the Society,s Judson Daland Prize on ... treatment of inherited immune deficiency diseases. The ...
... ... show co-host Casey Hobbs, RN, asks with an up-for-anything tone in her voice. A ... “Oh my God, death is imminent for you,” co-host Maggie McDermott, RN, deadpans in her ... ...
... Emedco Inc., a ... 16, 2009. The new site will be able to be accessed using the same ... enhanced shopping and ordering experience. , ... (PRWEB) November 18, 2009 -- The new website entailed thousands of man hours to ...
... ... on Contemporary Pharmacovigilance and Risk Management Strategies from January 10-13, 2010 in Washington, DC. ... Horsham, PA ... 9th Annual Conference on Contemporary Pharmacovigilance and Risk Management Strategies from January ...
Cached Medicine News:Health News:Thought-Controlled Game; Jedi Mind, Inc. Provides Update on Progress 2Health News:Moderate Drinking Guards the Heart 2Health News:Moderate Drinking Guards the Heart 3Health News:Immunology expert at Children's Hospital receives APS prize for patient-oriented research 2Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 2Health News:New National Nurse Talk Radio Show Takes Off with Humor, Health, and a Voice for the Patient Advocate 3Health News:Great Customer Service Just Got Better as Emedco Announces the Launch of their Completely Updated and Enhanced Website 2Health News:Great Customer Service Just Got Better as Emedco Announces the Launch of their Completely Updated and Enhanced Website 3Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 2Health News:DIA Safety Conference To Explore Solutions To Challenges Facing Pharmaocovigilance And Risk Management Strategies 3
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 23G x 7/8 in (.60 x 22mm). .3mm end port. Olive shape tip is 2mm long x 1mm w...
For administering anesthetic agents into the posterior sub-Tenon's space 20G x 1in (.90 x 25mm)...
For administering local anesthetic prior to ophthalmic surgery. 27G x 1 1/4 in (.40 x 32mm). May also be used for retrobulbar administration....
... is a complete vestibular diagnostic system ... movements collected via electrodes. Its Windows-based ... use. Saccade, tracking and Slow Phase ... is facilitated by graphic comparison of ...
Medicine Products: